The Valley Desk

NCT03118947 · Interventional trial

A Study of Pimavanserin for the Treatment of Agitation and Aggression in Subjects With Alzheimer's Disease

Overall registry status Completed

Phase 2

Conditions Agitation and Aggression in Alzheimer's Disease

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov